Evidence map›Paper›PMID 39941701›Full record

ArticleJournal of clinical medicine2025

Immune Checkpoint Inhibitor in Hepatocellular Carcinoma: Response Rates, Adverse Events, and Predictors of Response.

Shekhar Swaroop, Sagnik Biswas, Shubham Mehta, Arnav Aggarwal, Umang Arora, Samagra Agarwal, Amitkumar Chavan, Baibaswata Nayak, Shalimar

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shekhar SwaroopDepartment of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi 110029, India.ORCID 0000-0001-7792-6846
Sagnik BiswasDepartment of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi 110029, India.ORCID 0000-0003-3487-4921
Shubham MehtaDepartment of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi 110029, India.
Arnav AggarwalDepartment of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi 110029, India.
Umang AroraDepartment of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi 110029, India.ORCID 0000-0002-4366-0776
Samagra AgarwalDepartment of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi 110029, India.ORCID 0000-0002-2053-2069
Amitkumar ChavanDepartment of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi 110029, India.ORCID 0000-0002-7670-2792
Baibaswata NayakDepartment of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi 110029, India.ORCID 0000-0003-2238-6015
ShalimarDepartment of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi 110029, India.ORCID 0000-0003-1247-437X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancercirrhosisHCCimmunotherapyliver

Identifiers

PMID39941701
PMCPMC11818670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.